Related Experiment Video
Updated: Jun 14, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability
1Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
SSBP proteins bind and stabilize transcriptional cofactor LIM domain-binding protein1 (LDB1) from proteosomal degradation to promote tissue-specific transcription through an evolutionarily conserved pathway. The human SSBP2 gene was isolated as a candidate tumor suppressor from a critical region of loss in chromosome 5q14.1. By gene targeting, we show increased predisposition to B-cell lymphomas and carcinomas in Ssbp2(-/-) mice. Remarkably, loss of Ssbp2 causes increased LDB1 turnover in the thymus, a pathway exploited in Trp53(-/-)Ssbp2(-/-) mice to develop highly aggressive, immature thymic lymphomas. Using T-cell differentiation as a model, we report a stage-specific upregulation of Ssbp2 expression, which in turn regulates LDB1 turnover under physiological conditions. Furthermore, transcript levels of pTalpha, a target of LDB1-containing complex, and a critical regulator T-cell differentiation are reduced in Ssbp2(-/-) immature thymocytes. Our findings suggest that disruption of the SSBP2-regulated pathways may be an infrequent but critical step in malignant transformation of multiple tissues.
Insights
SSBP2 protein stabilizes LDB1, crucial for tissue-specific transcription. Its loss in mice increases lymphoma and carcinoma risk, highlighting SSBP2
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- SSBP proteins stabilize LIM domain-binding protein 1 (LDB1), essential for tissue-specific transcription.
- The SSBP2 gene, located at chromosome 5q14.1, is implicated as a potential tumor suppressor.
- Dysregulation of SSBP2 may contribute to malignant transformation.
Purpose of the Study:
- To investigate the role of SSBP2 in preventing cancer development.
- To elucidate the mechanism by which SSBP2 regulates LDB1 stability and transcription.
- To examine the impact of SSBP2 loss on T-cell differentiation and lymphoma development.
Main Methods:
- Gene targeting in mice to create Ssbp2(-/-) and Trp53(-/-)Ssbp2(-/-) models.
- Analysis of LDB1 turnover in thymocytes.
- Assessment of T-cell differentiation and transcript levels of LDB1 targets like pTalpha.
Main Results:
- Ssbp2(-/-) mice exhibit increased susceptibility to B-cell lymphomas and carcinomas.
- Loss of Ssbp2 leads to accelerated LDB1 degradation in the thymus.
- Reduced expression of pTalpha and impaired T-cell differentiation in Ssbp2(-/-) thymocytes.
Conclusions:
- SSBP2 is a critical regulator of LDB1 stability and plays a vital role in preventing lymphomas and carcinomas.
- Disruption of the SSBP2-LDB1 pathway is a significant factor in the malignant transformation of various tissues.
- Targeting SSBP2-regulated pathways may offer therapeutic strategies for specific cancers.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Single-Strand DNA Binding Proteins
The Intrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway
